CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 

Biotricity Inc 's Quick Ratio

BTCY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

 


Biotricity Inc 's Cash & cash equivalent grew by 175.17 % in the Q3 2024 sequentially, while Current Liabilities decreased, this led to improvement in Biotricity Inc 's Quick Ratio to 0.1, Quick Ratio remained below Biotricity Inc average.

Within Medical Equipment & Supplies industry 186 other companies have achieved higher Quick Ratio than Biotricity Inc in third quarter 2024. While Quick Ratio total ranking has improved so far during the Q3 2024 to 3767, from total ranking in the second quarter 2024 at 3795.

Explain Quick Ratio?
How much Cash & cash equivalents BTCY´s has?
What are BTCY´s Current Liabilities?


BTCY Quick Ratio (Dec 31 2024)
Q3
(Sep 30 2024)
Q2
(Jun 30 2024)
Q1
(Mar 31 2024)
Q4
(Dec 31 2023)
Q3
Y / Y Current Liabilities Change 13.55 % 42.34 % 84.39 % 211.34 % 324.24 %
Y / Y Cash & cash equivalent Change 563.05 % 11.09 % -42.8 % 26.54 % -89.27 %
Quick Ratio MRQ 0.1 0.03 0.03 0.05 0.02
BTCY's Total Ranking # 3767 # 3795 # 3143 # 3051 # 3784
Seq. Current Liabilities Change -1.62 % 4.42 % -9.34 % 21.91 % 23.32 %
Seq. Cash & cash equivalent Change 175.17 % 12.67 % -40.94 % 262.11 % -53.9 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 187
Healthcare Sector # 895
Overall Market # 3767


Quick Ratio Statistics
High Average Low
3.99 0.56 0.01
(Dec 31 2017)   (Dec 31 2015)




Financial Statements
Biotricity Inc 's Current Liabilities $ 21 Millions Visit BTCY's Balance sheet
Biotricity Inc 's Cash & cash equivalent $ 2 Millions Visit BTCY's Balance sheet
Source of BTCY's Sales Visit BTCY's Sales by Geography


Cumulative Biotricity Inc 's Quick Ratio

BTCY's Quick Ratio for the trailling 12 Months

BTCY Quick Ratio

(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 64.68 % 119.8 % 180.82 % 219.91 % 179.54 %
Y / Y Cash & cash equivalent TTM Growth 51.49 % -49.31 % -77.9 % -86.31 % -92.47 %
Quick Ratio TTM 0.05 0.03 0.04 0.05 0.06
Total Ranking TTM # 3755 # 3511 # 2895 # 3469 # 2995
Seq. Current Liabilities TTM Growth 3.03 % 8.3 % 13.94 % 29.54 % 37.51 %
Seq. Cash & cash equivalent TTM Growth 61.41 % 2.69 % -15.2 % 7.77 % -46 %


On the trailing twelve months basis BTCY Cash & cash equivalent more than doubled by 563.05 % in Q3 2024 year on year, faster than Current Liabilities, this led to increase in in Biotricity Inc 's Quick Ratio to 0.05, Quick Ratio remained below BTCY average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 211 other companies have achieved higher Quick Ratio than Biotricity Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 3511 to 3755.

Explain Quick Ratio?
How much Cash & cash equivalents BTCY´s has?
What are BTCY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 212
Healthcare Sector # 955
Within the Market # 3755


trailing twelve months Quick Ratio Statistics
High Average Low
2.54 0.56 0.03
(Jun 30 2022)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Quick RatioDec 31 2024 MRQ Cash & cash equivalentDec 31 2024 MRQ Current Liabilities
Seastar Medical Holding Corporation  0.27 $ 1.819  Millions$ 6.808  Millions
The Pennant Group Inc   0.24 $ 24.246  Millions$ 101.700  Millions
Ir med Inc   0.24 $ 0.129  Millions$ 0.545  Millions
Escalon Medical Corp   0.24 $ 0.521  Millions$ 2.211  Millions
Plus Therapeutics Inc   0.23 $ 3.606  Millions$ 15.551  Millions
Encision Inc   0.22 $ 0.348  Millions$ 1.611  Millions
Zimmer Biomet Holdings Inc   0.21 $ 525.500  Millions$ 2,450.900  Millions
Integer Holdings Corporation  0.21 $ 46.543  Millions$ 219.821  Millions
Dexcom Inc   0.21 $ 606.100  Millions$ 2,901.500  Millions
Predictive Oncology Inc   0.20 $ 0.735  Millions$ 3.593  Millions
Bioventus Inc   0.20 $ 41.582  Millions$ 210.398  Millions
Steris Plc  0.18 $ 155.178  Millions$ 858.669  Millions
Ufp Technologies Inc   0.18 $ 13.450  Millions$ 76.295  Millions
Bausch and Lomb Corp  0.18 $ 305.000  Millions$ 1,738.000  Millions
Dentsply Sirona Inc   0.17 $ 272.000  Millions$ 1,589.000  Millions
Sharps Technology Inc   0.17 $ 0.864  Millions$ 5.186  Millions
National Vision Holdings Inc   0.16 $ 73.948  Millions$ 468.274  Millions
Iridex Corp  0.14 $ 2.387  Millions$ 16.559  Millions
Interpace Biosciences Inc   0.14 $ 1.461  Millions$ 10.615  Millions
Globus Medical Inc   0.12 $ 105.619  Millions$ 855.913  Millions
The Cooper Companies Inc   0.12 $ 100.900  Millions$ 873.300  Millions
Patterson Companies Inc   0.10 $ 134.996  Millions$ 1,305.421  Millions
Stimcell Energetics Inc   0.10 $ 0.034  Millions$ 0.329  Millions
Biotricity Inc   0.10 $ 2.055  Millions$ 21.141  Millions
Enovis Corp  0.09 $ 48.167  Millions$ 528.998  Millions
Dynatronics Corporation  0.09 $ 0.791  Millions$ 9.210  Millions
P3 Health Partners Inc   0.08 $ 38.816  Millions$ 496.415  Millions
Mountain Crest Acquisition Corp V  0.08 $ 0.117  Millions$ 1.521  Millions
Qhslab Inc   0.07 $ 0.157  Millions$ 2.407  Millions
Boston Scientific Corporation  0.06 $ 414.000  Millions$ 6,399.000  Millions

Date modified: 2025-04-11T08:54:34+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com